In parallel, we investigated TREM-1 expression directly by immunofluorescence staining using a breast tumor tissue microarray consisting of >40 invasive ductal and lobular carcinomas positive or negative for the clinical markers ER, PGR and HER-2. This evidence concerns the gene ERBB2 and breast lobular carcinoma.